Borderline personality disorder (BPD) is a severe, high-suicidal psychiatric disorder associated with impulsive, endangering behaviors. Young patients between 16 and 25 years old do not respond to traditional psychotherapies, which are often long and not adapted to their neurocognitive alterations linked to early trauma. The study authors hypothesize the SINTYA therapy program (one group session and one individual session weekly for 10 weeks) would reduce the level of impulsivity and clinical symptomatology (severity of the BPD; emotional regulation difficulties; dissociative symptoms; aggressiveness; ruminations; the number of self-destructive behaviors and suicidal acts; impulsive behaviors; level of suicide risk and hopelessness; the number of psychiatric hospitalizations and emergency visits for psychiatric reasons; and finally improving psychosocial functioning).
Diagnosis of BPD according to DSM-5 criteria and BPQ-80 scale.
High BPD severity level: ZAN-BPD (score ≥ 18/36).
Understand, write and read French.
Be able to understand the nature, purpose and methodology of the study and agree to cooperate during evaluations.
Refusal to participate.
Existence of a neurological pathology or cerebral sequelae of organic origin which could affect neurocognitive performance.
Intelligence quotient < 70.
Lifetime diagnosis of schizoaffective disorder or schizophrenia (MINI-7).